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SypHerThe mitochondrial oxidative phosphorylation (OXPHOS) system consists of four electron transport chain (ETC)
complexes (CI–CIV) and the FoF1-ATP synthase (CV), which sustain ATP generation via chemiosmotic coupling.
The latter requires an inward-directed proton-motive force (PMF) across the mitochondrial inner membrane
(MIM) consisting of a proton (ΔpH) and electrical charge (Δψ) gradient. CI actively participates in sustaining
these gradients via trans-MIM proton pumping. Enigmatically, at the cellular level genetic or inhibitor-induced
CI dysfunction has been associated with Δψ depolarization or hyperpolarization. The cellular mechanism of the
latter is still incompletely understood. Here we demonstrate that chronic (24 h) CI inhibition in HEK293 cells in-
duces a proton-basedΔψ hyperpolarization in HEK293 cells without triggering reverse-mode action of CV or the
adenine nucleotide translocase (ANT). Hyperpolarization was associated with low levels of CII-driven O2 con-
sumption and prevented by co-inhibition of CII, CIII or CIV activity. In contrast, chronic CIII inhibition triggered
CV reverse-mode action and induced Δψ depolarization. CI- and CIII-inhibition similarly reduced free matrix
ATP levels and increased the cell's dependence on extracellular glucose to maintain cytosolic free ATP. Our ﬁnd-
ings support a model in which Δψ hyperpolarization in CI-inhibited cells results from low activity of CII, CIII and
CIV, combined with reduced forward action of CV and ANT.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are double-membrane organelles involved in numer-
ous cellular processes like apoptosis induction, reactive oxygen species
generation, adaptive thermogenesis, ion homeostasis and innate im-
mune responses [1]. Classically, mitochondria also act as key suppliers
of cellular energy by providing the machinery that generates ATP from
the energy stored in NADH and FADH2. The latter two molecules arerial innermembrane;Δψ, mito-
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man).generated by the glycolysis pathway in the cytosol (NADH) and the tri-
carboxylic acid (TCA) cycle in the mitochondria (NADH and FADH2),
and are oxidized at complex I (CI) and complex II (CII) of the electron
transport chain (ETC), respectively. The released electrons are then
transported to complex III (CIII) by coenzyme Q (CoQ) and subsequent-
ly to complex IV (CIV) by cytochrome c (cyt c). At the latter complex, the
electrons react with molecular oxygen (O2) to form water. Electron
transport is energetically coupled to the translocation of protons from
the mitochondrial matrix across the mitochondrial inner membrane
(MIM) at CI, CIII and CIV. This results in an inward-directed proton-
motive force (PMF) across the MIM that consists of a chemical (ΔpH)
and an inside-negative electrical gradient (Δψ).
Protons are allowed to ﬂow back into the mitochondrial matrix via
the FoF1-ATP-synthase (CV) to drive the synthesis of ATP from ADP
and inorganic phosphate (Pi). Together with CV, the four complexes of
the ETC constitute the oxidative phosphorylation (OXPHOS) system.
By reverse-mode action CV can also hydrolyse ATP and expel protons
from the mitochondrial matrix thereby sustaining Δψ [2]. This mecha-
nism requires that ATP is transported from the cytosol to themitochon-
drial matrix by reverse-mode action of the mitochondrial adenosine
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substrate-level phosphorylation [3].
A sufﬁciently large PMF is not only required to sustain ATP produc-
tion but also is of crucial importance for mitochondrial fusion, protein
import, metabolite exchange with the cytosol, and apoptosis induction
(e.g. [4–8]). In this sense, Δψ can be considered as an important func-
tional readout of mitochondrial health.
Mitochondrial dysfunction is a hallmark of (rare) metabolic disor-
ders and also associated with normal human ageing, neurodegenera-
tion, certain forms of cancer and metabolic syndrome [1,6–12].
Aberrations in Δψ have been observed in a wide variety of cells with
inherited OXPHOS dysfunction. For instance cells with CV malfunction
displayed Δψ hyperpolarization (i.e. the MIM was more inside-
negative; [13,14]). In case of CI, we demonstrated that its partial enzy-
matic deﬁciency (i.e. residual CI activities between 18 and 75% of lowest
controls) was associated with a minor decrease in Δψ (depolarization)
in primary skin ﬁbroblasts from patients with inherited CI deﬁciency
[15,16]. Similarly, Δψ depolarization was observed in healthy primary
skin ﬁbroblasts when CI was partially and speciﬁcally inhibited by
chronic treatment (72 h) with the CI inhibitor rotenone (ROT) [5,17].
In contrast, CI enzymatic deﬁciencywas associatedwithΔψhyperpolar-
ization in immortalized mouse embryonic ﬁbroblasts (MEFs) derived
from whole-body knockout mice lacking the key CI subunit NDUFS4
[18]. Also in neurons, glial-like cells and their undifferentiated stem
cells genetic CI dysfunction was accompanied by Δψ hyperpolarization
[19]. Interestingly, whereas the Δψ of CI-deﬁcient neurons seemed to
be sustained by CV reverse-mode action, CV ran in forward mode in
CI-deﬁcient stem cells suggesting a cell type-speciﬁc regulation [19].
Compatiblewith these ﬁndings, speciﬁc CI inhibition (4h) by a submax-
imal concentration of ROT inducedΔψ hyperpolarization in 143B osteo-
sarcoma cells [20]. However, in these cells Δψ depolarized when ROT
was used at higher concentrations (N100 nM) and/or at longer incuba-
tion times. In contrast, Δψ hyperpolarization was induced when ROT
was used at higher concentrations (i.e. N100 nM) but shorter incubation
times (i.e. 30 min–2 h) in Leishmania donovani promastigotes [21], cor-
onary artery smooth muscle cells [22] and neutrophils, but not in pe-
ripheral blood mononuclear leukocytes [23]. Taken together, it
appears that CI functional impairment triggers Δψ hyperpolarization
in a manner that (co)depends on the cell-type, inhibitor concentration
and duration of inhibitor treatment.
This study aims to gain insight into the mechanism underlying Δψ
hyperpolarization during chronic CI dysfunction. As a model system
we used HEK293 cells in which Δψ hyperpolarization was triggered by
chronic (24 h) incubation with the CI inhibitor ROT. Analysis of this
model suggests thatΔψhyperpolarization during reduced CI activity re-
quires low activity of CII, CIII and CIV in combination with greatly re-
duced forward activity of CV and the ANT.
2. Materials and methods
2.1. Generation of inducible HEK293 cell lines stably expressing cytosolic or
mitochondria-targeted SypHer variants
Gateway® Entry vectors were generated by recombining Gateway-
adapted PCR products containing the sequence encoding cyto-HyPer
andmito-HyPer frompHyPer-cyto and pHyPer-dMito vectors (Evrogen,
Moscow, Russia) with pDONR201 (Invitrogen, Breda, The Netherlands).
A Gateway-adapted tag-less pcDNA/FRT/TODestination vector was cre-
ated by recombining the acGFP1-Destination vector [24–26] with a
BacMamVSV-Destination vector [27]. To create constructs encoding
the pH sensor SypHer, the mito-HyPer and cyto-HyPer Entry vectors
weremutated at a critical cysteine residue by site-directedmutagenesis
as described previously [28]. These new Entry vectors were recombined
with the Gateway-adapted pcDNA/FRT/TO Destination vector to obtain
mito-HyPer, mito-SypHer, cyto-HyPer and cyto-SypHer expression
vectors. Flp-In T-REx293 cells (Invitrogen) were stably transfectedwith the expression vectors described above using the SuperFect Trans-
fection Reagent (Qiagen, Venlo, The Netherlands) and cultured for se-
lection in the presence of 200 μg/ml hygromycin (Calbiochem,
Brunschwig, Amsterdam, The Netherlands) and 50 μg/ml blasticidin
(Invitrogen). To induce expression of the biosensor, 1 μg/ml doxycy-
cline (Sigma-Aldrich, Zwijndrecht, The Netherlands) was added to the
culture medium, followed by incubation for 24 h.
2.2. Generation of inducible HEK293 cell lines stably expressing cytosolic or
mitochondria-targeted variants of ATeam 1.03 and “dead-ATeam”
The ATeam sequence was isolated from pcDNA3-AT1.03 and
pcDNA3-mito-AT1.03 vectors [29], and selection markers and acGFP1
were removed from the acGFP1-Destination vector by digestion. The
ATeamsequencewas then ligated into the remainingDestination vector
to obtain the pcDNA5/FRT/TO/cyto-ATeam and pcDNA5/FRT/TO/mito-
ATeam expression vectors. Flp-In T-REx293 cells (Invitrogen) were sta-
bly transfected as described above. “Dead” ATeamwas expressed in the
cells using baculoviral transduction. To this end, the pcDNA3-
AT1.03R122K/R126K vector [29] was subcloned into cyto-ATeam and
mito-ATeam Entry vectors using EcoRV and EcoRI to obtain a mutated
ATP-unresponsive ATeam. Next, we recombined the Entry vectors
with a Gateway-adapted BacMamVSV-Destination vector to obtain
baculoviruses as described before [18]. Flp-In T-REx293 cells were seed-
ed 48 h before imaging, and transfectionwas induced by the addition of
7% v/v baculovirus. The “dead” ATeam transfected cells were imaged
and analyzed in the same way as the ATeam stable cell lines.
2.3. Cell culture and inhibitor treatment
Flp-In T-REx293 cells were cultured in DMEM containing 25 mM
glucose, 2 mM L-glutamine, 10% (v/v) fetal calf serum and 1% penicil-
lin/streptomycin in a humidiﬁed atmosphere containing 5% CO2 at
37 °C. Prior to transfection, parental Flp-In TREx cells were cultured in
the presence of 50 μg/ml blasticidin and 100 μg/ml Zeocin (Invitrogen).
For ﬂuorescence microscopy, 100,000 cells were seeded on 24-mm
coverslips (Thermo Scientiﬁc, Etten-Leur, The Netherlands) placed in
35-mm CellStar tissue culture dishes (Sigma-Aldrich) or 35-mm glass-
bottom culture dishes (Fluorodish,World Precision Instruments, Berlin,
Germany) two days before imaging. For respirometry, the cells were
grown to 80% conﬂuence. One day after seeding, cells were treated
with ROT, piericidin A (PA) or antimycin A (AA) for 24 h and compared
with vehicle (0.1% ethanol)-treated (CT) cells.
2.4. High-resolution respirometry
Culture medium was collected, and cells were trypsinised, washed
and resuspended to approximately one million cells/ml in the collected
culture medium. Two ml of this suspension was used to measure cellu-
lar oxygen consumption. Oxygen consumption was measured at 37 °C
using a two-chamber Oxygraph (Oroboros Instruments, Innsbruck,
Austria) using an established protocol [30]. For inhibitor titration exper-
iments, cells were allowed to respire for 10 min (routine respiration),
after which ETC inhibitors were added in subsequent 1-μl volumes. As
a control, identical additions were carried out using a vehicle (ethanol)
solution.
For analyses in permeabilized cells, 1–1.5 million cells were resus-
pended in mitochondrial respiration medium [31] and, following base-
line recording, CI-dependent respiration (10 mM glutamate, 2 mM
malate, 1 mM ADP) was initiated by permeabilization with 2 μg/ml sa-
ponin. Then a maximum of 10 mM succinate was added (titration) to
measure CI + CII, and respiration of CII substrates only was assessed
by the addition of 100 nMROT. Following determination of residual ox-
ygen consumption using 2.5 μM AA, maximum CIV-dependent respira-
tion was measured using 2 mM ascorbate and 0.5 mM TMPD. Finally,
1249M. Forkink et al. / Biochimica et Biophysica Acta 1837 (2014) 1247–1256the integrity of the mitochondrial outer membrane (MOM) was tested
using 10 μM cyt c.2.5. Fluorescence imaging of free ATP levels
Free ATP levels were quantiﬁed using a ﬂuorescence resonance
energy transfer (FRET)-based reporter protein (‘ATeam’ 1.03). This sen-
sor is comprised of the ε subunit of the bacterial FoF1-ATP synthase
sandwiched between cyan- and yellow-ﬂuorescent protein variants
[29]. The coverslips were washed with PBS, covered with HEPES-Tris
(HT) buffer (containing 132 mM NaCl, 10 mM HEPES, 4.2 mM KCl,
1 mM MgCl2, 1 mM CaCl2 and 25 mM D-glucose, adjusted to pH 7.4
with Tris) and mounted in an incubation chamber that was placed on
the temperature-controlled (37 °C) stage of an inverted microscope
(Axiovert 200M, Carl Zeiss, Jena, Germany) equipped with a ×40 1.3 NA
Fluar oil-immersion objective. The cyan ﬂuorescent protein (CFP) of
ATeamwas excited at awavelength of 430nm, and the yellowﬂuorescent
protein (YFP) was excited at 435 nm for 300 ms using a monochromator
(Polychrome IV, TILL Photonics, Gräfelﬁng, Germany) and a 455DRLP
dichroic mirror (Omega Optical Inc., Brattleboro, VT, USA). CFP and YFP
emissions were directed through 480AF30 and 535AF26 (Omega) emis-
sionﬁlters, respectively, and captured using a CoolSNAPHQmonochrome
CCD camera (Roper Scientiﬁc, Évry, France). Microscopy hardware was
controlled using MetaFluor 6.0 software (Universal Imaging Corporation,
Downingtown, PA, USA). Ten ﬁelds of view were routinely analysed per
coverslip. In time-lapse measurements a superfusion system [32] was
used with a ﬂow rate of 1.5 ml/min, and images were captured at an in-
terval of 6 s. Imageswere analysedusingMetaMorph6.1 (Universal Imag-
ing Corporation).2.6. Fluorescence imaging of cytosolic and mitochondrial pH
Mitochondrial and cytosolic pH were measured in Flp-In T-Rex293
cells stably overexpressing the pH sensor SypHer. The latter was excited
at 420 nm and 470 nm during 200 ms, directed by a 505DRLPXR
(Omega) dichroic mirror. Emission signals were captured using a
535AF45 (Omega) emission ﬁlter using the microscopy system de-
scribed above. Ten–ﬁfteen ﬁelds of view were routinely analysed per
coverslip.2.7. Fluorescence imaging of mitochondrial membrane potential
Flp-In T-Rex293 cells were incubated with 50 nM of tetramethyl
rhodaminemethyl ester (TMRM; Invitrogen) in collected culture medi-
um for 25min at 37 °C and 5% CO2 in the dark. The coverslips were then
washedwith PBS and imaged in HT buffer. Images were acquired on the
microscope system described above using a 540-nm excitation wave-
length directed for 100 ms by a 560DRLP (Omega) dichroic mirror
through a 565ALP (Omega) emission ﬁlter. For each coverslip, 10–25
ﬁelds of view were routinely acquired and analysed using MetaMorph
6.1 (Universal Imaging Corporation). For time-lapse measurements,
the images were recorded at 2-second intervals (carbonyl cyanide-4-
triﬂuoromethoxyphenyl-hydrazone; FCCP) or 6-second intervals
(oligomycin A; OLI or bongkrekic acid; BA).2.8. Fluorescence imaging of mitoAcGFP1
Stable Flp-InT-REx293 cell lines expressing cox8-AcGFP1 [24] were
excited at 488 nm for 300 ms, directed by a 505DRLPXR (Omega) di-
chroic mirror. Emission signals were captured using a 515ALP
(Omega) emission ﬁlter using the microscopy system described above.
Ten ﬁelds of view were routinely analysed per coverslip.2.9. Immunocytochemistry
The cells were ﬁxed using 4% formaldehyde in PBS for 15 min and
permeabilized in 0.5% Triton X-100 in PBS for 20 min. After washing
with 0.05% (v/v) Tween-20 in PBS, the cells were blocked in blocking
buffer containing 2% (w/v) bovine serum albumin (BSA), 2% (v/v) nor-
mal goat serum (NGS), 0.1% (v/v) Triton X-100, 0.05% (v/v) Tween-20,
and 100 mM glycine in PBS for 30 min. To determine tubulin morphol-
ogy, the cells were incubated with the primary antibodies mouse anti-
beta-tubulin (1:300, E7 IgG1). This antibody was developed by Michael
Klymkowsky and obtained from the Developmental Studies Hybridoma
Bank developed under the auspices of the NICHD and maintained by
The University of Iowa, Department of Biological Sciences, Iowa City,
IA 52242. Bound anti-beta-tubulin was visualized with AlexaFluor-
488-labeled goat anti-mouse IgG1 (1:200; Molecular Probes). The cells
were sealed using VECTASHIELD mounting medium containing 4′,6-
diamidino-2-phenylindole (DAPI), which stains all nuclei (Vector Labo-
ratories, Burlingame, CA, USA) and visualized using a Zeiss Axiophot2
ﬂuorescence microscope with AxioCam MRm CCD camera.
2.10. Electrophysiology
Electrophysiological measurements of plasma membrane resting
potential were performed using the perforated patch technique
(50 μM β-escin, Sigma-Aldrich) [33]. Data acquisition was performed
using an EPC-9 ampliﬁer and PatchMaster software (HEKA Electronics,
Lambrecht, Germany). Pipettes were pulled from thin-walled borosili-
cate glass (Harvard Apparatus) and had resistance between 2 and
3 MΩ, when ﬁlled with pipette solution (120 mM KCl, 25 mM NaCl,
1 mM CaCl2, 1 mM MgCl2, 3.5 mM EGTA, 10 mM HEPES, adjusted to
pH 7.3 using KOH). A perforated patch was generally obtained within
15 min following the establishment of the gigaseal. Plasma membrane
resting potentials were obtained by injecting zero current in the current
clamp-recording mode.
2.11. Data analysis and statistics
Curve ﬁtting was performed using Origin Pro 6.1 (OriginLab Corp.,
Northampton, MA, USA). Additional image processing and analysis
were carried out using Image Pro Plus 6.3 software (Media Cybernetics,
Silver Spring, MD, USA). Unless stated otherwise, data is presented as
mean ± SE (standard error). Statistical signiﬁcance was assessed
using a Kruskal–Wallis 2-way ANOVA following Dunn's multiple com-
parison test, or a Mann–Whitney t-test using GraphPad Prism 5 soft-
ware (GraphPad Software Inc., La Jolla, CA, USA). Asterisks indicate
statistical signiﬁcance: ⁎P b 0.05, ⁎⁎P b 0.01 and ⁎⁎⁎P b 0.001.
3. Results
3.1. Acute rotenone treatment dose-dependently and incompletely inhibits
O2 consumption in intact cells
Triggered by experimental evidence in the literature (see Introduc-
tion) we ﬁrst investigated whether it was possible to induce Δψ hyper-
polarization in HEK293 cells by chronic treatment with the CI inhibitor
ROT. However, when used at inappropriately high concentrations ROT
can also display off-target effects on the cellular tubulin network. This
might indirectly affect mitochondrial function (e.g. [5,20,34–37]). To
avoid this potential problem we ﬁrst determined the lowest ROT con-
centration that maximally inhibited cellular O2 consumption when
acutely added to intact cells (Fig. 1A). Up to a concentration of 1 μM,
ROTwas unable to fully block respiration (i.e. down to the level of resid-
ual O2 consumption; “ROX”). Similar results were obtained with the CI-
speciﬁc inhibitor PA (Fig. 1A). Compatiblewith a previous binding study
[38], PA displayed a somewhat lower IC50 than ROT. In contrast to ROT
and PA, acute treatment with the CIII inhibitor AA (Fig. 1A) fully
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Fig. 1. Chronic complex I inhibition decreases cellular O2 consumption and hyperpolarizes themitochondrial membrane potential. (A) Stepwise inhibition of CI (ROT or PA) and CIII (AA)
decreases the O2 consumption of intact HEK293 cells in cell culture medium. Data points were ﬁtted using a logistic model (R2 N 0.99) to calculate IC50 values. Each data point reﬂects the
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shown). (D) Typical example of TMRM-stained HEK293 CT cells and regions of interest (‘m’) for analysis of mitochondrial TMRM ﬂuorescence intensity. (E) Effect of chronic treatment
with ROT, PA or AA on mitochondrial TMRM ﬂuorescence intensity. (F) The resting plasma membrane potential of inhibitor-treated (100 nM, 24 h) cells, measured by patch-clamping
in two independent experiments. (G) Effect of chronic 100 nM ROT and AA treatment on mitochondrial GFP ﬂuorescence intensity in mito-AcGFP1 expressing HEK293 cells after 24 h
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to use a 100 nMROT concentration during chronic cell treatment (24 h).
Control experiments revealed that this treatment regime did not induce
alterations in cell shape/size and organisation of the cellular tubulin net-
work as detected with immunocytochemistry methods (data not
shown).3.2. Chronic rotenone treatment incompletely inhibits O2 consumption in
intact and permeabilized cells
Similar to acute ROT addition, chronic ROT treatment greatly re-
duced cellular O2 consumption (Fig. 1B; grey bars vs. black bars).
This O2 consumption was insensitive to CV inhibition by OLI or mito-
chondrial uncoupling (FCCP). However, addition of ROT+ AA slight-
ly but signiﬁcantly reduced O2 consumption, suggesting that still
some ETC activity remains in ROT-treated cells. To further dissect
how chronic ROT treatment impacts on ETC-mediated O2 consump-
tion we analysed the effect of chronic ROT treatment in perme-
abilized cells (Fig. 1C; grey bars). Using CI- (glutamate + malate), CII-(succinate + ROT) and CI + CII-selective (glutamate + malate + suc-
cinate) substrate conditionswe observed that CI-dependent respiration
was reduced (but not absent) and CII-dependent respiration was nor-
mal in ROT-treated cells. In contrast, cells chronically treated with AA
(100 nM, 24 h) displayed greatly reduced O2 consumptionwhen respir-
ing on CI or CII substrates.3.3. Chronic rotenone treatment induces Δψ hyperpolarization and in-
creases ΔpH
Chronic ROT treatment dose-dependently increased mitochondrial
TMRM ﬂuorescence compatible with a hyperpolarized (more negative)
Δψ (Fig. 1D and E). Whereas a similar increase was observed in cells
chronically treated with PA, chronic AA treatment reduced mitochon-
drial TMRM ﬂuorescence (suggesting Δψ depolarization). Since the ex-
tent of mitochondrial TMRM accumulation also depends on the
membrane potential of the plasma membrane (ΔV), it is of crucial im-
portance to determine whether ROT treatment induces ΔV hyperpolar-
ization [39]. Electrophysiological analysis revealed that chronic ROT
1251M. Forkink et al. / Biochimica et Biophysica Acta 1837 (2014) 1247–1256treatment did not signiﬁcantly alter ΔV whereas AA induced a depolar-
ization (Fig. 1F). These results argue against amechanismwhereΔψ hy-
perpolarization in ROT-treated cells is caused by ΔV hyperpolarization.
Since we used epiﬂuorescence microscopy, and given the fact that
TMRM is a single-excitation/single-emission reporter molecule, chang-
es in mitochondrial and/or cellular volume and/or thickness can also af-
fect TMRM ﬂuorescence intensity. In this way, ROT-induced cellular
and/ormitochondrial swellingmight lead to an increased TMRM signal.
We argued that if this would be the case, the emission intensity of an-
other single-excitation/single-emission (but Δψ-independent) reporter
molecule (i.e. a mitochondria-targeted GFP) should also be increased.
However, ROT did not increase and AA did not signiﬁcantly decrease
the mitochondrial ﬂuorescence signal of mito-AcGFP1 (Fig. 1G). This
makes it highly unlikely that the ROT-induced increase inmitochondrial
TMRM signal is due to cellular and/ormitochondrial swelling. Finally, to
rule out interference of TMRM ﬂuorescence autoquenching we per-
formed time-lapse recordings to analyse the kinetics of the mitochon-
drial TMRM signal during protonophore (FCCP) application (Fig. 2A).
Instead of a temporary increase in TMRM ﬂuorescence (associated
with autoquenching), FCCP induced a rapid ﬂuorescence drop in vehicle
(CT), ROT, AA and PA-treated cells (Fig. 2A). This demonstrates theD E
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3.4. Chronic rotenone treatment does not induce matrix acidiﬁcation
FCCP induced a faster mitochondrial TMRM release in CI-inhibited
cells (Fig. 2B), suggesting that Δψ hyperpolarization is proton-
dependent. To determine whether ROT treatment affected mitochon-
drial and cellular pH homeostasis we created two HEK293 cell lines sta-
bly expressing cytosolic and mitochondria-targeted variants of the pH-
sensing protein “SypHer” (Fig. 2C), the ﬂuorescence emission ratio of
which increases as a function of pH [28]. Importantly, cyto- and mito-
SypHer display identical pH-dependent changes in their emission ratio
signal [28] allowing their quantitative comparison. In CT cells the pH
within the mitochondrial matrix (pHmito) was more alkaline than the
pH in the cytosol (pHcyto; Fig. 2D) reﬂecting the presence of a matrix-
directed PMF across the MIM. ROT treatment reduced pHcyto but did
not alter pHmito, whereas AA treatment reduced both pHcyto and pHmito
(Fig. 2E). We calculated the difference between the mitochondrial and
cytosolic SypHer ﬂuorescence for each condition and used this numberF
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(ΔpH). This difference was increased in ROT-treated cells and reduced
in AA-treated cells (Fig. 2F), suggesting that the differential effects of
these inhibitors on Δψ (partially) result from a change in trans-MIM
proton gradient.
3.5. Chronic rotenone treatment does not induce reverse-mode action of
complex V and the ANT
If ROT-induced Δψ hyperpolarization is primarily proton-based, it
might result from an increased trans-MIM proton ﬂux out of thematrix
and/or a reduced trans-MIM proton inﬂux into the matrix. Under
conditions of ETC inhibition, Δψ hyperpolarization has been linked to
reverse-mode action of CV and consumption of ATP [2,3,40]. When
substrate-level phosphorylation cannot provide enough ATP to fuel CV
reverse-mode action Δψ will further depolarize. To counterbalance
this effect also the ANT can operate in reverse to bring in ATP and
negative charge from the cytosol into the mitochondrial matrix [3].
Inhibition of CV (usingOLI) or the ANT (using BA) did not induceΔψde-
polarization in CT and ROT-treated cells (Fig. 3). BA similarly affected
Δψ in AA-treated cells whereas OLI induced Δψ depolarization. Of
note, in these experiments TMRM was also present outside the cell to
allow for increasedmitochondrial TMRMuptake duringΔψhyperpolar-
ization. Qualitatively, these results suggest that: (i) CV and ANT
operate in forward mode in CT cells, (ii) CV nor ANT reverse-mode ac-
tion is involved in sustaining Δψ in ROT-treated cells, and (iii) CV
operates in reverse-mode and ANT operates in forward mode in AA-
treated cells.
3.6. Chronic rotenone treatment lowers mitochondrial free ATP levels
Above we provided evidence that ROT treatment greatly decreases
cellular O2 consumption and hyperpolarizes Δψ, accompanied by an in-
crease in ΔpH. Moreover, the differential effects of CV inhibition (OLI)
on Δψ in ROT- and AA-treated cells (Fig. 3) suggest that also steady-
state mitochondrial ATP levels, which depend on the balance between
ATP production, ATP consumption and ANT-mediated exchange,
might be differentially affected. In CT cells, CV inhibition decreases cel-
lular respiration by N70%, indicating that these cells contain an active
mitochondrial ATP production supported by CV forward operation
(Fig. 1B; black bars). CV inhibition did not depolarize but, in contrast
to CT cells, also did not greatly hyperpolarize Δψ in ROT-treated cells.
This suggests that CV activity is reduced in ROT-treated cells. Therefore
it appears that in ROT-treated cells the driving force of the PMF is
uncoupled from CV-mediated ATP production. To address this hypothe-
sis we generated two HEK293 cell lines stably expressing cytosolic and
mitochondria-targeted variants of the ATP-sensing protein “ATeam”
(Fig. 4A), the ﬂuorescence emission ratio of which increases as a func-
tion of free ATP concentration [29]. As controls, we expressed cytosolic
and mitochondria-targeted variants of an ATP-insensitive ATeam vari-
ant (“dead ATeam” [29]) using a baculoviral expression system. In CT
cells the ﬂuorescence emission ratio of mito-ATeam was lower than
that of cyto-ATeam (Fig. 4B; black bars), whereas these ratios were
lower but identical for dead mito-ATeam and dead cyto-ATeam (white
bars). This demonstrates that both cyto- and mito-ATeam variants
bind ATP and that [ATP]m is lower than [ATP]c in HEK293 cells. The
mito-ATeam emission ratio was reduced in ROT- and AA-treated cells
(Fig. 4C; left panel). These treatments did not decrease the emission
ratio of dead mito-ATeam (Fig. 4C; right panel). Taken together, this
demonstrates that [ATP]m is reduced in ROT- and AA-treated cells. Al-
though ROT- and AA-treatment did not alter the emission ratio of
cyto-ATeam (data not shown), suggesting that [ATP]c is not affected,
we did not use this data since [ATP]c might be far above the ATP afﬁnity
of this sensor [41]. However, when glucose (GLU) in the extracellular
medium was replaced by an equimolar amount of the competitive
hexokinase inhibitor 2-Deoxy-D-Glucose (2DG) the cyto-ATeam ratioin CT cells dropped within 15 min to that of dead cyto-ATeam
(Fig. 4D). This means that cytosolic ATP was fully depleted within this
time period. Upon 2-DG application [ATP]c decreased much faster in
ROT- and AA-treated cells than in CT cells (Fig. 4E). These results, in
combination with the observed low O2 consumption values, demon-
strate that inhibitor-treated cells are more glycolysis-dependent than
CT cells for maintaining their [ATP]c. Taken together, these data suggest
that CV is less involved in residual mitochondrial ATP production in CI-
inhibited cells, despite the presence of a substantial PMF.3.7. Chronic inhibition of complex II, III or IV prevents rotenone-inducedΔψ
hyperpolarization
The above results argue against involvement of CV and ANT reverse-
mode action in ROT-induced Δψ hyperpolarization. Moreover, because
[ATP]m is decreased and oxygen consumption is reduced, it seems
that CV is less active in CI-inhibited cells. This hypothesis is supported
by our result that Δψ was most sensitive to FCCP-induced proton leak
in ROT- or PA-treated cells (Fig. 2B). This suggests that activity of
other ETC complexes (CII, CIII and CIV) is required to allow ROT-
induced Δψ hyperpolarization. Chronic inhibition of CII (MALO), CIII
(AA) or CIV (KCN) resulted in reduced mitochondrial TMRM ﬂuores-
cence compatible with Δψ depolarization (Fig. 5). For the purpose of
comparison, we have included the data for 100 nM ROT and AA
from Fig. 1E in Fig. 5. Interestingly, ROT-induced Δψ hyperpolarization
was prevented by chronic co-inhibition of CII (ROT + MALO), CIII
(ROT + AA) or CIV (ROT + KCN) (Fig. 5), suggesting that activity of
these complexes plays an essential role in the hyperpolarization
mechanism.
Inhibition of CII alone and CI + CII reduced mitochondrial
TMRM ﬂuorescence to a similar extent, whereas inhibition of CI + CIII
and CI + CIV was less efﬁcient (Fig. 5). Since in ROT-treated cells CII-
driven respiration is unchanged compared to CT (Fig. 1C) but
respiration on endogenous substrates is low (Fig. 1B), it seems that CII
activity drives a low level of electron transport in ROT-treated cells.
Therefore we conclude that CII plays a key role in sustaining Δψ
1254 M. Forkink et al. / Biochimica et Biophysica Acta 1837 (2014) 1247–1256hyperpolarization in ROT-treated cells by fuelling electron transport to
CIII and CIV.
4. Discussion
Chemical or mutation-induced inhibition of the mitochondrial ETC
reduces proton efﬂux across the MIM and is generally associated with
(partial) Δψ depolarization [5,42]. However, various (patho)physiolog-
ical conditions including mitochondrial CI deﬁciency have been linked
to Δψ hyperpolarization [18–23], the mechanism of which is incom-
pletely understood. Herewe demonstrate that chronic (24 h) treatment
with the mitochondrial CI inhibitor ROT induces Δψ hyperpolarization
in HEK293 cells. This model system was used to study the mechanism
of mitochondrial hyperpolarization during chronic CI dysfunction.A
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and AA-treated cells displayed lower O2 consumption when respiring
on CI-selective substrates. In contrast, ROT-treated cells exhibited nor-
mal O2 consumption when respiring on CI + CII- or CII-selective sub-
strates whereas these parameters were greatly reduced in AA-treated
cells. These results suggest that the greatly reduced O2 consumption in3-
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tion and subsequent electron transport to CIII and CIV. However, we
cannot rule out that a low remaining CI activity co-contributes to resid-
ual ROT-sensitive O2 consumption in the ROT-treated cells. In case of
AA, its full inhibition of O2 consumption is compatible with the very
low rates on CI, CII and CI + CII-selective substrates.
Single cell microscopy analysis was used to quantify accumulation of
the Δψ-dependent ﬂuorescent cation TMRM within the mitochondrial
matrix. It was found that chronic ROT and PA treatment dose-
dependently increased the mitochondrial TMRM ﬂuorescence signal.
Chronic treatment with 100 nM AA, a concentration that fully blocked
cellular O2 consumption, induced a decrease in this signal. Importantly,
the intensity of themitochondrial TMRM ﬂuorescence not only depends
onΔψ but also can be affected by the potential of the plasmamembrane
(ΔV), changes in mitochondrial and/or cellular volume and/or thick-
ness, and TMRM autoquenching. However, control experiments re-
vealed that these “artifacts” were not responsible for the observed
ROT-inducedΔψhyperpolarization. In case of AA treatment a signiﬁcant
ΔV depolarization was observed suggesting that the reduced TMRM ac-
cumulation under these conditionsmight be overestimated. In the light
of the above, we conclude that the ROT-induced increase in mitochon-
drial TMRM accumulation truly reﬂects Δψ hyperpolarization that is as-
sociated with CI inhibition. It appears that this hyperpolarization is CI-
speciﬁc, since it was dose-dependently increased by ROT or PA and
not induced by chronic inhibition of the other ETC complexes. When
cells were cultured in the chronic presence of ROT + AA, ROT
+ MALO or ROT + KCN, no Δψ hyperpolarization was observed. This
strongly suggests that Δψ hyperpolarization in ROT-treated cells re-
quires activity of these complexes, supporting our above conclusion
that CII-mediated substrate oxidation and electron transport to CIII
and CIV sustains the greatly reduced O2 consumption in these cells.
However, we cannot exclude the presence of CoQ-mediated electron
entry via other enzymes like the electron-transferring ﬂavoprotein
(ETF)-ubiquinone oxidoreductase, s,n-glycerophosphate dehydroge-
nase and dihydroorotate dehydrogenase (see Ref. [5] and the references
therein). ROT- and PA-inhibited cells were particularly sensitive to
chemical uncoupling by FCCP. This demonstrates that Δψ is (partially)
carried byprotonsunder these conditions and primedus to quantifymi-
tochondrial and cellular pH using the protein-based sensor SypHer. The
SypHer analysis demonstrated that pHmito N pHcyto, indicative of an in-
ward directed trans-MIM proton gradient, allowing forward-mode (i.e.
ATP producing) action of CV. The latter is compatible with our observa-
tion that CT cells displayed an OLI-sensitive O2 consumption meaning
that their mitochondria were actively producing ATP. Whereas chronic
ROT-treatment decreased pHcyto, pHmito was unaffected, suggesting a
lack of net proton accumulation into the mitochondrial matrix. In case
of AA, both pHmito and pHcyto became more acidic. Semi-quantitative
calculation of ΔpH revealed that this gradient was increased in ROT-
treated and slightly decreased in AA-treated cells, suggesting that a dif-
ference in ΔpH might contribute to Δψ hyperpolarization and
depolarization.
In healthy cells, net Δψ not only depends on ETC activity but also on
forward- or reverse-mode action of CV and theANT. For instance,we re-
cently demonstrated that a greatly reduced CV expression and CVmax-
imal activity was linked to Δψ hyperpolarization in ﬁbroblasts of
patients with TMEM70 mutations [14]. Qualitative experiments re-
vealed that acute inhibition of CV using OLI does not induceΔψ depolar-
ization in CT or ROT-treated cells. In contrast, acute CV inhibition rapidly
depolarized Δψ in AA-treated cells. These data demonstrate that CV
runs in reverse-mode in AA-treated cells whereas this is not the case
in CT and ROT-treated cells. CV reverse-mode action in AA-treated
cells likely is fuelled by ATP derived from mitochondrial substrate-
level phosphorylation [3,43]. Our current results are supported by a pre-
vious study where we investigated immortalized embryonic ﬁbroblasts
of NDUFS4−/−mice, a genetic model of CI deﬁciency [18]. In these cells
we also observed that Δψ hyperpolarization in NDUFS4−/−MEFs wasmaintained in the absence of CV reverse-mode action. Acute ANT inhibi-
tion by BA did not induce Δψ depolarization in CT and ROT- or AA-
treated cells, meaning that the ROT- and AA-induced effects on Δψ in
these cells do not involve ANT reverse-mode action. We propose that
the increased dependency of AA-treated cells on extracellular glucose
to sustain their [ATP]c might reﬂect a lack of mitochondrial ATP produc-
tion and transport to the cytosol. In this sense, ROT-treated cells ap-
peared slightly less dependent on extracellular glucose, compatible
with reduced activity of CV and the ANT.
5. Conclusions
Taken together, our results support a model (Fig. 6B), in which ROT-
induced CI inhibition greatly reduces but not completely blocks cellular
O2 consumption. This residual O2 consumption (CIV activity) is associat-
ed with substrate oxidation (CII activity) and proton efﬂux (CIII and CIV
activity). ROT-treated cells displayed a very low residual O2 consump-
tion,Δψhyperpolarization and an increasedΔpH. This strongly suggests
that also CV and ANT activity (both running in forwardmode) are great-
ly reduced. The latter effect might be enhanced by the drop in cytosolic
pH, known to inhibit CV and ANT activity during lactate accumulation in
glycolytic cells [3]. Both ROT- or AA-treated cells displayed a similarly
reduced mitochondrial free ATP concentration ([ATP]m). In ROT-
treated cells, this drop likely results from reduced CV/ANT forward
mode action. In case of AA-treatment the lower [ATP]m arises from CV
reverse-mode action, the lack of ANT reverse mode action, and the in-
ability of substrate level phosphorylation to meet the ATP demand of
CV (Fig. 6C). We postulate that in ROT-treated cells Δψ hyperpolariza-
tion is the net result of: (i) a greatly reduced matrix proton efﬂux (CIII
and CIV), (ii) a greatly reduced proton inﬂux (via CV) (iii) a low-level
ANT-mediated inﬂux of positive charge, and (iv) an increase in ΔpH
due to cytosolic acidiﬁcation. The latter was also observed in AA-
treated cells and likely results from upregulation of the glycolysis path-
way [43].
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